Discover Seventure's video
Seventure Partners Life Sciences Investing Update – H2 2017
“2017 ended on a high note. Our Health For Life...
Enterome raises €32 million ($38.5 million) in a Series D financing
ENTEROME SA, a clinical-stage biotech company pioneering...
Vedanta Biosciences announces initiation of Phase 1a/1b trial for new drug class of rationally-defined bacteria consortia derived from the human microbiome
VE303 is first known rationally-defined bacterial...
Vedanta Biosciences Expands Network of Clinical Collaborations Supporting Development of Microbiome Therapeutics for Cancer Immunotherapy
New collaborations with Leiden University Medical Center...
Enhanced understanding of the microbiome is helping medicine via The Economist
Enterome, Eligo Bioscience and Seventure Partners inside...
Microbiome Drug Development Summit – Paris, 29-31 January
Come & meet us !
Seventure at the Paris Fintech Forum 30 & 31 January 2018
Come and meet us !
Next Gen Immunology – Rehovot (Israel), 14-16 February
5th Microbiome R&D and Business Collaboration Forum: Europe – Rotterdam, 21-22 March